Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Capper

Showing results (171-180 of 350) with videos related to

Pageof 35
Sort By:
Journal of Neurosurgery. Pediatrics|July 28, 2022
Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG 2004 cohortUlrich-Wilhelm Thomale, Astrid K Gnekow, Daniela Kandels, et al.
Acta Neuropathologica|April 13, 2017
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic driversAndrey Korshunov, Daniel Schrimpf, Marina Ryzhova, et al.
Oncotarget|October 6, 2017
Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose fluxElena I Ilina, Angela Armento, Leticia Garea Sanchez, et al.
Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.
Acta Neuropathologica|April 11, 2025
CNS angiocentric stromal tumor (CAST), PDGFRA-mutant, a novel entity histologically mimicking meningioangiomatosis and radiologically correlating with giant Virchow-Robin spacesEkin Guney, Kanish Mirchia, Simone Schmid, et al.
Clinical Epigenetics|October 4, 2021
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification statusPhilipp Jurmeister, Karsten Weber, Sonia Villegas, et al.
Acta Neuropathologica|May 13, 2015
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHODavid E Reuss, Yasin Mamatjan, Daniel Schrimpf, et al.
Acta Neuropathologica|August 20, 2016
Evidence of H3 K27M mutations in posterior fossa ependymomasMarco Gessi, David Capper, Felix Sahm, et al.
Neuro-Oncology|July 22, 2022
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patientsRichard Drexler, Ulrich Schüller, Alicia Eckhardt, et al.
Neuro-Oncology|July 28, 2018
DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatmentHendrik Witt, Dorothee Gramatzki, Bettina Hentschel, et al.
Pageof 35

Showing results (171-180 of 350) with videos related to

Sort By:
Pageof 35
Journal of Neurosurgery. Pediatrics|July 28, 2022
Long-term follow-up of surgical intervention pattern in pediatric low-grade gliomas: report from the German SIOP-LGG 2004 cohortUlrich-Wilhelm Thomale, Astrid K Gnekow, Daniela Kandels, et al.
Acta Neuropathologica|April 13, 2017
H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic driversAndrey Korshunov, Daniel Schrimpf, Marina Ryzhova, et al.
Oncotarget|October 6, 2017
Effects of soluble CPE on glioma cell migration are associated with mTOR activation and enhanced glucose fluxElena I Ilina, Angela Armento, Leticia Garea Sanchez, et al.
Neuro-Oncology|July 17, 2014
Assessing CpG island methylator phenotype, 1p/19q codeletion, and MGMT promoter methylation from epigenome-wide data in the biomarker cohort of the NOA-04 trialBenedikt Wiestler, David Capper, Volker Hovestadt, et al.
Acta Neuropathologica|April 11, 2025
CNS angiocentric stromal tumor (CAST), PDGFRA-mutant, a novel entity histologically mimicking meningioangiomatosis and radiologically correlating with giant Virchow-Robin spacesEkin Guney, Kanish Mirchia, Simone Schmid, et al.
Clinical Epigenetics|October 4, 2021
DNA methylation profiling identifies two distinct subgroups in breast cancers with low hormone receptor expression, mainly associated with HER2 amplification statusPhilipp Jurmeister, Karsten Weber, Sonia Villegas, et al.
Acta Neuropathologica|May 13, 2015
IDH mutant diffuse and anaplastic astrocytomas have similar age at presentation and little difference in survival: a grading problem for WHODavid E Reuss, Yasin Mamatjan, Daniel Schrimpf, et al.
Acta Neuropathologica|August 20, 2016
Evidence of H3 K27M mutations in posterior fossa ependymomasMarco Gessi, David Capper, Felix Sahm, et al.
Neuro-Oncology|July 22, 2022
DNA methylation subclasses predict the benefit from gross total tumor resection in IDH-wildtype glioblastoma patientsRichard Drexler, Ulrich Schüller, Alicia Eckhardt, et al.
Neuro-Oncology|July 28, 2018
DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatmentHendrik Witt, Dorothee Gramatzki, Bettina Hentschel, et al.
Pageof 35